Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. HCW Biologics Inc.
  6. News
  7. Summary
    HCWB   US40423R1059

HCW BIOLOGICS INC.

(HCWB)
  Report
Delayed Nasdaq  -  03:42 2022-06-29 pm EDT
2.150 USD   +0.94%
06/17HCW BIOLOGICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/23HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022
AQ
05/19HCW BIOLOGICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index

09/20/2021 | 12:00am EDT
share with twitter
share with LinkedIn
share with facebook

HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index


© S&P Capital IQ 2021
All news about HCW BIOLOGICS INC.
06/17HCW BIOLOGICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/23HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference ..
AQ
05/19HCW BIOLOGICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/13Earnings Flash (HCWB) HCW BIOLOGICS Reports Q1 Revenue $3.12M
MT
05/13HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
05/13HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
GL
05/13HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
AQ
05/05HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
GL
05/05HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
AQ
More news
Analyst Recommendations on HCW BIOLOGICS INC.
More recommendations
Financials (USD)
Sales 2022 3,11 M - -
Net income 2022 -17,8 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,34x
Yield 2022 -
Capitalization 77,0 M 77,0 M -
Capi. / Sales 2022 24,8x
Capi. / Sales 2023 -
Nbr of Employees 44
Free-Float 40,6%
Chart HCW BIOLOGICS INC.
Duration : Period :
HCW Biologics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCW BIOLOGICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 2,15 $
Average target price 7,00 $
Spread / Average Target 226%
EPS Revisions
Managers and Directors
Hing C. Wong Chief Executive Officer, Secretary & Director
Rebecca Byam Chief Financial Officer
Scott T. Garrett Chairman
Peter R. Rhode Chief Scientific Officer & VP-Clinical Operations
Rick Scott Greene Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HCW BIOLOGICS INC.-8.19%76
GILEAD SCIENCES, INC.-14.32%78 031
VERTEX PHARMACEUTICALS25.76%70 632
REGENERON PHARMACEUTICALS, INC.-5.87%64 046
WUXI APPTEC CO., LTD.-14.46%44 352
BIONTECH SE-45.76%33 979